Norway has loaned all 216,000 of its AstraZeneca COVID-19 jabs to neighboring Sweden and Iceland.
Norway’s well being ministry mentioned doses would solely be loaned if the nation continues to droop use of the jab AstraZeneca (Vaxzevria).
On March 11, Norway adopted Denmark in deciding to droop the deployment of jabs by the Anglo-Swedish firm after stories of extraordinarily uncommon blood clots and continued to clear residents with different jabs developed by Pfizer / BioNTech and Moderna.
“Sweden and Iceland wish to borrow Norwegian doses of vaccine from AstraZeneca that are in inventory on the Nationwide Institute of Public Well being,” the ministry mentioned in an announcement.
“Norway will lend doses to Sweden and Iceland so long as the vaccine is on hiatus on this nation.”
Sweden will obtain 200,000 doses of Vaxzevria, whereas Iceland will obtain 16,000 doses from the stockpile, the ministry added.
The loaned vaccines have a shelf life that expires in June and July.
“I’m comfortable that the vaccines we now have in inventory might be helpful even when the AstraZeneca vaccine is placed on maintain in Norway,” Well being Minister Bent Høie mentioned.
“Sweden has a demanding an infection scenario and has supplied vital assist to Norway in working with entry to vaccines.”
However Høie reiterated that Sweden and Iceland would return the doses if Norway’s personal authorities regulator resumed use of the vaccine.
“If the usage of the AstraZeneca vaccine is resumed, we are going to get well the doses we lend as quickly as we request them,” mentioned the minister.
“Sweden and Iceland will then return the doses of their first deliveries of AstraZeneca.”
The European Medicines Company (EMA) has mentioned the advantages of being proof against COVID-19 outweigh the very uncommon danger of growing blood clots probably linked to the Anglo-Swedish vaccine.
Norway, a non-EU member, additionally mentioned that sooner or later their vaccines might be given to different nations within the bloc “in collaboration” with Brussels.
Though the Norwegian Institute of Public Well being has beneficial eradicating the AstraZeneca vaccine from the Norwegian vaccination program, the federal government has determined to attend, saying it “believes that we do not need a robust sufficient foundation to attract a conclusion. closing”.
The nation’s well being ministry reiterated that specialists will overview the usage of Vaxzevria and the Johnson & Johnson vaccine – which use the identical adenovirus know-how – earlier than Could 10.
On Tuesday, Denmark introduced that it could additionally mortgage 55,000 doses of AstraZeneca to the neighboring German state of Schleswig-Holstein.
The Danish authorities mentioned it had “not but determined” what to do with different surplus vaccines, however was in dialogue with a number of nations.